Profile of Predictive Factors of Response to Therapy in Patients with Diffuse Large B-cell Lymphoma in dr Soetomo General Teaching Hospital Surabaya

• المؤلفون الرئيسيون: Mochammad Dilliawan, -, Siprianus Ugroseno Yudho Bintoro, -, Putu Niken Ayu Amrita, -
• التنسيق: مقال PeerReviewed
• اللغة: English; English; English; English
• منشور في: Ektodermal Displazi Grubu 2020
• الموضوعات: R Medicine (General); RC Internal medicine
• الوصول للمادة أونلاين: http://repository.unair.ac.id/109568/1/3.%20Profile%20of%20Predictive%20Factors%20of%20Response%20to%20Therapy%20in%20Patients%20with%20Diffuse%20Large%20B-cell.pdf; http://repository.unair.ac.id/109568/2/Profile%20of%20Predictive.pdf; http://repository.unair.ac.id/109568/3/Bukti%20Korespondensi%20Profile%20of%20Predictive.pdf; http://repository.unair.ac.id/109568/4/Profile%20of%20Predictive%20Factors%20of%20Response%20to%20Therapy%20in%20Patients%20with%20Diffuse%20Large%20B-cell%20Lymphooma%20in%20dr%20Soetomo%20General%20Teaching%20Hospital%20Surabaya.pdf; http://repository.unair.ac.id/109568/; http://www.jidmr.com/journal/wp-content/uploads/2020/06/67-M20_1102_Hendrik_Setia_Budi_Siprianus_U_Y_B_Indonesia.pdf

Despite the use of rituximab as a substantial treatment for Diffuse Large B-Cell Lymphoma (DLBCL), the survival rate remains low due to high incidences of relapse. Several predictive factors for relapse have been investigated however, still expensive and not applicable. Lymphocytemonocyte ratio (LMR...